Dawn Lim

Counsel

Disclaimer

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

Dawn Lim is a corporate counsel in O'Melveny's New York office. Dawn previously assisted MNCs with U.S. international tax structuring and planning opportunities at a large public accounting firm, where she was part of the international tax practice in its Philadelphia, New York, and Singapore offices.

Languages

  • Korean

Admissions

Bar Admissions

  • New York

Education

  • University of Pennsylvania Law School, J.D.: Editor (vol. 35) and Executive Technology editor (vol. 36) for University of Pennsylvania Journal of International Law, Pamela Daisy Award.
  • University of Rochester, B.A. in Economics,: cum laude

In the News

Press Releases

O’Melveny Advises B. Riley Securities as Sole Placement Agent on Private Placement Financing of US$55 Million Series A Preferred Stock of Ribbon Communications

April 13, 2023

O’Melveny Represents B. Riley Securities as Sole Bookrunner on Public Equity Offering of Bed Bath & Beyond

February 21, 2023

O’Melveny Represents Beauty Farm in US$100 Million Hong Kong IPO

January 16, 2023

O’Melveny Represents Cryofocus in its Hong Kong IPO

December 30, 2022

O’Melveny Represents 3D Medicines Inc. in US$52 Million Hong Kong IPO

December 15, 2022

O’Melveny Represents Rainmed Medical in its Hong Kong IPO

July 8, 2022

O’Melveny Represents Atlanta Braves and SWB Investors on Sale of Four Minor League Baseball Teams

March 15, 2022

O’Melveny Represents Acotec Scientific in US$210 Million Hong Kong IPO

August 24, 2021

O’Melveny Represents Underwriters in Hong Kong IPO of Shanghai HeartCare Medical Technology Corporation Limited

August 20, 2021

O’Melveny Advises Todd Boehly In Acquisition of Minority Interest in the Los Angeles Lakers

July 9, 2021

Alerts and Publications